Cargando…
Convulsant bicuculline modifies CNS muscarinic receptor affinity
BACKGROUND: Previous work from this laboratory has shown that the administration of the convulsant drug 3-mercaptopropionic acid (MP), a GAD inhibitor, modifies not only GABA synthesis but also binding of the antagonist [(3)H]-quinuclidinyl benzilate ([(3)H]-QNB) to central muscarinic receptors, an...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463000/ https://www.ncbi.nlm.nih.gov/pubmed/16615872 http://dx.doi.org/10.1186/1471-2202-7-32 |